Medicare Rx Formulary Decisions Open To “Manipulation,” Attorney Says

The process for creating prescription drug formularies under the Medicare Rx law leaves the potential for "manipulation" by drug plans, Sidley Austin Brown & Wood Partner Bill Sarraille told a Pharma Audioconference Feb. 10